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Background: Understanding the pathogenesis of influenza infection is a key factor leading to the prevention and
control of future outbreaks. Pandemic 2009 Influenza H1N1 infection, although frequently mild, led to a severe and
fatal form of disease in certain cases that make its virulence nature debatable. Much effort has been made toward
explaining the determinants of disease severity; however, no absolute reason has been established.
Results: This study presents the heterogeneous virulence of clinically similar strains of pandemic 2009 influenza
virus in human alveolar adenocarcinoma cells and mice. The viruses were obtained from patients who were
admitted in a local hospital in China with a similar course of infection and recovered. The A/Nanchang/8002/2009
and A/Nanchang/8011/2009 viruses showed efficient replication and high lethality in mice while infection with A/
Nanchang/8008/2009 was not lethal with impaired viral replication, minimal pathology and modest
proinflammatory activity in lungs. Sequence analysis displayed prominent differences between polymerase subunits
(PB2 and PA) of viral genomes that might correlate with their different phenotypic behavior.
Conclusions: The study confirms that biological heterogeneity, linked with the extent of viral replication, exists
among pandemic H1N1 strains that may serve as a benchmark for future investigations on influenza pathogenesis.
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Following the emergence of the initial few cases in Mex-
ico and California in 2009, the world faced another epi-
sode of pandemic caused by the novel influenza A H1N1
virus (pdm H1N1 hereafter) that carried a unique com-
bination of gene segments from four different lineages
[1]. The virus spread so rapidly that within two months
of the first confirmed report, the World Health
Organization (WHO) declared a level VI global emer-
gency alert. Epidemiologic observations affirm the pres-
ence of seasonal flu imprints in pandemic H1N1 strains
such as high attack rate with mild presentation and self-
limiting infection in the majority of human cases [2];* Correspondence: dkelvin@uhnresearch.ca
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reproduction in any medium, provided the orhowever, some of them led to severe respiratory illness
and eventually death [3,4]. Absence of known virulence
markers such as lysine (K) residue at 627 in PB2 and the
multi-basic cleavage site in hemagglutinin (HA), as well
as truncated PB1-F2 and NS1 proteins [1], support the
modest morbidity profile of pandemic H1N1 viruses. In
addition, several in vivo studies conducted in ferrets and
mice confirm the subtle disease profile due to pdm
H1N1 despite its efficient replication in the lower re-
spiratory tract of the host coupled with increased levels
of innate and adaptive immune mediators [5-7]. How-
ever, severe and fatal human cases are reasonably
explained by the presence of underlying host illness and
bacterial co-infections that dysregulate host immune
functions and consequently weaken host’s ability to con-
trol viral replication [8-10]. One can consider the im-
portant role of host-associated factors in disease
outcome, the reason pdm H1N1 behaved differently in
humans remains elusive. Recently, Safronatz et al.
reported the diversified behavior of pdm H1N1 strainsal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Genetic, demographic and Clinical background of
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£Observed in MDCK cells, NA: not available, ND: not detected, €Mutations are
compared with prototypic strain: A/California/07/2009 H1N1.
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cates the possible link between viral heterogeneity and
degree of disease severity[11].
Several laboratory animals including mice, ferrets, cot-
ton rats and nonhuman primates have been successfully
used as suitable models of influenza infection [12].
Among them ferrets are considered the best because oftheir natural susceptibility to the virus and its similar
pathogenesis to that of humans [13]; however, their use
in large-scale screening is not feasible. Small laboratory
animals, particularly mice, have shown promising poten-
tial for virological studies. We have previously described
the infection of prototypic pdm H1N1 strain, A/ Mex-
ico/4108/2009 in mice with significant viral replication
and marked lung pathology [14].
The high magnitude of the 2009 pandemic and poten-
tial risk of future outbreaks necessitate the evaluation of
newer viral strains to resolve ambiguities about the se-
verity of infection. In this study, we evaluated three dif-
ferent H1N1 influenza viruses that were isolated from
adult patients admitted in a local hospital in the south-
ern part of China during the second pandemic wave.
Interestingly, these strains exhibited mild to severe
pathogenic potential in terms of viral replication, disease
progression, and induction of proinflammatory response
in vitro and in vivo. Sequence analysis reveals that the
mutations in polymerase subunits (PB2 and PA) might
correlate with the phenotypic trait of the viruses. This
study presents the co-circulation of heterogeneous pdm
H1N1 during this period that cannot be a neglected fac-
tor in evaluating the pathogenesis of 2009 pandemic in-
fluenza infection.
Results
Differential response of pdm H1N1 strains in A549 cells
To better understand the pathogenesis profile of local
isolates, we randomly selected three strains of pdm
H1N1, namely A/Nanchang/8002/2009 (NC2), A/Nan-
chang/8008/2009 (NC8), and A/Nanchang/8011/2009
(NC11). All were isolated from adult patients with severe
clinical profiles and without underlying illnesses (Table
1). First we evaluated the replication and inflammatory
response of these strains in human adenocarcinoma al-
veolar epithelial (A549) cells that were inoculated with
each viral strain at multiplicity of infection (MOI) 2. Out
of three, two pdm H1N1 strains (NC2 and NC11) exhib-
ited severe cytopathic effects while, unexpectedly, NC8
caused only mild infection in A549 cells. Viral titration
of culture supernatants was performed in MDCK cells at
different time points. Kinetics studies showed that NC2
and NC11 grew in high titers in 24 h which was further
increased in 48 h while NC8 showed poor replication
capacity throughout the study period (P< 0.0001)
Impaired replication of NC8 was also verified by signifi-
cantly lower viral mRNA and protein levels over the
period of 24 h post infection. Confocal laser fluorescent
microscopy showed that NC8 was capable of infecting
cells but replication was delayed compared to that of
NC2 infection (Figure 1)
Transcriptional analysis of major inflammatory media-
tors was performed by real time PCR at four different
Figure 1 Comparison of viral replication kinetics in A549 cells. A549 cells were infected with viral strains; NC2, NC8 and NC11 at MOI 2. (a)
shows the viral titers in cell supernatants 24 and 48 h post infection (P< 0.0001). (b) shows viral mRNA levels in infected cells and (c) Nuclear
localization of viral NP protein was noticeably slow in cases of NC8 infection at 4 h that led to no or negligible yield of viral progeny in cell
cytoplasm at 8 h post infection. Red shows staining of viral NP protein and blue shows nucleus specific DAPI stain. Micrographs are taken at the
magnification of 40 (for 4 h and 8 h) and at 20 for 24 h.
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observed that NC8 was unable to mount efficient in-
flammatory response as a consequence of its poor repli-
cation. As shown in Figure 2, CXCL10 expression was
mute in cases of NC8 infection compared with NC2 and
NC11 throughout the study period (P< 0.0001). In
addition, cellular interferon responses including inter-
feron (IFN) γ, IFN αA2 (P< 0.0001), and IL29 (P
<0.0068) were also weak after NC8 infection compared
with NC2 and NC11; however, in the case of IFN- γ, sig-
nificant difference was observed only in 24 h (P< 0.05).
A similar difference was observed in the case of IL6 at
24 h post infection (P 0.0176). Conclusively, immune
mediators peaked between 8 to 24 h after NC2 and
NC11 infection, while minimal variations in the gene ex-
pression were observed in NC8-infected cells.
The above-mentioned results indicated relatively poor
replication ability of the NC8 strain in mammalian cells
coupled with weak inflammatory response that prompted
us to scrutinize how NC8 behaves in an avian environ-
ment. In contrast with A549 cells, a different situation was
observed in chicken embryo nated eggs in which thevirus titers of NC8 were higher than those from NC2
and NC11 (Table 1).
Differential pathogenesis of pdmH1N1 strains in mice
We next evaluated the pathogenesis of NC2, NC8 and
NC11 viruses in C57/BL6 mice (Figure 3). Each group of
animals was infected with the same dose of influenza
virus intranasally and observed for weight loss and le-
thality up to 14 days. Most strikingly, these viral strains,
with apparently the same clinical profile in humans,
behaved differently in C57/BL6 mice in lethality (P
0.0007) and weight loss (P 0.0007). When using 20%
weight loss as the humane point, NC2 was 100% lethal
within four d.p. i. at 105 EID50. At the same viral dose,
NC11 exerted 90% lethal response within eight d.p.i., al-
though no significant difference was noted in median
death day (MDD), number of survivors and weight loss
kinetics between the two viral strains. On the other
hand, the same infection dose of NC8 did not cause
death in animals while the virus at 10-fold concentration
(106 EID50), resulted only in 30% lethality (P< 0.001)
coupled with a significant dichotomy in clinical course of
Figure 2 Comparison of infection with different strains of pdmH1N1 virus in A549 cells. The figure shows the comparative analysis of
cellular immune mediators after NC2, NC8 and NC11 infection. Cells were infected with respective viral strains while mock infection with HBSS
was given to blank. At different time points, mRNA expression of different cytokine/chemokine genes was measured by real time RT-PCR. Results
are presented as log 2 of mean arbitrary units ± SEM. Data are compared by Mann Whitney U test. *** _P< 0.0001, **_ P <0.001, * _ P <0.01.
Farooqui et al. Virology Journal 2012, 9:104 Page 4 of 12
http://www.virologyj.com/content/9/1/104infection within the NC8 infected group. Weight losses
were milder and delayed as compared with those of the
other groups (P< 0.001). The weight loss kinetics of indi-
vidual animals infected by each virus is given in additional
file 1. Taken together, these wild type pdm H1N1 strains
showed heterogeneous attitude in C57/BL6 mice.Figure 3 Comparison of the virulence of three pandemic H1N1 strain
C57/BL6 mice (n = 10/group). Viral infection was established with 105 EID50
14 days. (a) Kaplan Meier’s analysis shows overall difference in survival curv
curves: NC2 vs NC8 (P< 0.0001), NC2 vs NC11 (P 0.0195) and NC8 vs NC11
NC2, NC8 and NC11. Significant differences were observed at 3 d.p.i., NC8 vTo confirm the heterogeneous nature of NC2 and
NC8, viral infection was further established in C57/BL6
and BALB/C mice in a dose dependent manner. In
addition, comparisons between the survival curves of
C57/BL6 and BALB/C were analyzed since different
mouse strains might differ in susceptibility of wild types in C57/BL6 mice. Viral strains NC2, NC8 and NC11 were analyzed in
of NC2, NC11 and 106 EID50 of NC8 and animals were observed up to
es (P 0.0007). Log-rank sum test shows differences between mortality
(P 0.0007). (b) Weight loss curve for the group of animals infected with
s NC2 (P< 0.0001), NC8 vs NC11 (0.0007).
Figure 4 Analysis of biological heterogeneity in different mice strains in dose dependent manner. Pandemic H1N1 viruses (NC2 and NC8)
were compared in C57/BL6 and BALB/C mice in dose dependent manner. Weight losses (a, c) and lethality (b, d) are shown for animals (n = 10/
group) infected with varying concentrations of viral strains (103, 104, 105 and 106). Log rank sum test shows significant differences in mortality
curves between NC2 and NC8 irrespective of inocula and mice strain (P< 0.0001). ). (a, c): Inter-group comparisons in weight loss shows
significant difference NC2 vs NC8 groups (P< 0.0001), C57/BL6 vs BALB/C; NC2_ 104 (P< 0.0001), NC2_105 (P< 0.0001). (b, d): Survival differences
are also significant in C57/BL6 vs BALB/C after NC2 infection: 104 (P< 0.0028), 105 (P 0.0005), 106 (P 0.0669).
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to viral infection than BALB/C; however, the trend was
clearer at low viral doses. In general, NC2 infected mice
faced 100% lethality irrespective of viral dose; however,
they exhibited dose dependent kinetics in weight loss
and survival curve with an extension of MDD from days
3 to 7 at high (105 EID) and low viral inocula (103 EID)
respectively. In contrast, NC8 was unable to mount
lethal infection irrespective of viral inocula and animal
strains except 30% lethality with modest weight loss in
C57/BL6 mice infected with 106 EID50 (Figure 4). These
observations clearly demonstrate the presence of two
different virulence phenotypes of pdm H1N1 strains, of
which one seems to be better adapted to mammalian
hosts than the other.
Altered replication of viral strains in mice
We also determined the replication and organ distribu-
tion (viral loads) of pdm H1N1 strains in differentanimal body tissues by cell culture method. Lung
homogenates of NC2 and NC8 infected (105 EID50)
C57/BL6 mice mimic the viral replication profile of
A549 cells at 1 d.p.i. with slightly enhanced viral titers of
NC11 (Figure 5a); however, all three viral strains grew at
the same rate at 3 d.p.i. (data not shown). The results in-
dicate delayed replication of NC8 that might provide a
chance for the host immune system to overcome the in-
fection, which eventually results in a non-lethal infec-
tion. Comparison of viral replication of NC2 in lungs of
BALB/C and C57/BL6 mice showed that NC2 at 105
EID50 replicated well in both mouse strains. To further
understand the growth pattern of NC2 and NC8 strains,
we titrated lung homogenates of BALB/C mice infected
with dose series of the viruses. We found that NC8 was
not able to replicate at day 1. Although day 3 showed
signs of NC8 replication in animal lungs, the viral titers
were still significantly lower than those of NC2
(P< 0.002) (Figure 5). No extrapulmonary viral spread
Figure 5 Heterogonous viral replication of pandemic influenza H1N1 strains in mice lungs. (a) Viral loads in the lungs of NC2, NC8 and
NC11 infected C57/BL6 mice were determined at 1 d.p.i.. (b) Viral loads NC2 were also examined in C57/BL6 and BALB/C mice (n =3). Replication
kinetics of NC2 and NC8 were compared in BALB/C mice infected with dose series of viruses at (c) 1 d.p.i. and (d) 3 d.p.i.. MDCK cells were used
to determine viral loads in serially diluted lung homogenates collected at different time intervals. Results are presented as mean± SEM of TCID50.
Statistical differences were calculated by Mann Whitney U test. *** - P< 0.0001.
Farooqui et al. Virology Journal 2012, 9:104 Page 6 of 12
http://www.virologyj.com/content/9/1/104was evidenced. The results endorsed the above observa-
tions and confirmed that early viral replication contri-
butes to the pathogenesis of pandemic H1N1 infection.
Lung pathology
The extent of alveolar damage caused by NC2 and NC8
was assessed by histology over time. Figure 6 presents
the comparison of haematoxylin and eosin (H&E)
stained infected lung tissues. In C57/BL6 mice, NC2
caused mild to moderate cellularity in interstitial space
at 1 d.p.i. compared with NC8, which did not show any
sign of inflammation (Figure 6a and b). Severe interstitial
inflammation with damaged alveolar structure, moderate
cellular exudates, and hemorrhage in the lumen and
peribronchial spaces were noticed after three days of
NC2 infection (Figure 6c and d). Alveolar edema and
distortion of respiratory epithelium was also observed in
NC2 infected BALB/C mice (Figure 6e). In contrast,inflammatory scores were much lower after three days
of NC8 infection as shown in Figure 6f. Histological
observations support the heterogeneous nature of NC2
and NC8 infection as observed by survival and viral rep-
lication experiments.
Evaluation of host immune responses
First we compared the ability of NC2, NC11 and NC8
viruses to induce host inflammatory immune response in
animals. C57/BL6 mice were infected with equal amount
of viruses while mock infection with HBSS was adminis-
tered to the blank group. We also noted whether weight
loss and viral replication patterns were similar to those in
the above-mentioned experiments. As expected, the gene
expression of major immune mediators including
CXCL10, IFNβ, TNFα, IL29 and IL6 of NC2 and NC11
infected mice was more pronounced than in those who
were infected with NC8. At 1 d.p.i., the expression of
Figure 6 Lung pathology of mice infected with different viral strains. The figure shows lung pathology of C57/BL6 mice at 1 d.p.i. (a) and
3d.p.i. (c and d) and BALB/C at 3 d.p.i. (e) after NC2 infection. In contrast NC8 infected C57/BL6 mice show no (b) and very mild (f) pathological
signs at 1 and 3 d.p.i. respectively. Thin arrows – inflammation in interstitial space; thick arrows – hemorrhage in respiratory bronchioles; white
arrows – infiltrating cells in lumen of terminal bronchiole; curved arrows – inflammation in peribronchial area; white triangle – pulmonary edema;
white cross – damaged epithelium.
Figure 7 Evaluation of host immune mediators. Transcriptional data for major host immune response genes (b-f) and viral mRNA levels (a)
are shown at 1d.p.i. in C57/BL6 mice infected with 105 EID50 of various strains of pandemic H1N1 influenza virus (NC2, NC8 and NC11) and mock
infection with HBSS was given to blank animals. Results are presented as mean± SEM of mRNA levels normalized with mouse β-actin gene.
Statistical differences were calculated by Mann Whitney U test. ** - P< 0.001, * - P< 0.01.
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http://www.virologyj.com/content/9/1/104major inflammatory mediators CXCL10 and IFN β was
upregulated in NC2 and NC11 infected groups, while the
highest increase in the expression of TNFα and IL28A
was observed in NC11 and NC2 respectively (Figure 7).
On the other hand, transcriptional analysis of NC8
infected C57/BL6 mice showed attenuated response com-
pared with NC2 and NC11 (P< 0.0001), mimicking the
data obtained from A549 cells probably due to inefficient
viral replication.
On the basis of the above-mentioned data, we chose
the NC2 infection model to compare the kinetic
response in BALB/C and C57/BL6 mice by real time RT-
PCR analysis. More robust gene expression was
observed in C57/BL6 mice compared with BALB/C, who
showed comparatively attenuated responses throughout
the experiment. In C57/BL6 mice, proinflammatory re-
sponse was marked with significant induction of early
immune mediators such as CXCL10, IFN β and TNFα.
The trend was similar for IL6, indicating the classical
switching of innate and adaptive arms. The highest level
of expression was achieved at 1 d.p.i. in each case with
the exception of IL28A, which was progressively
increased over time (additional file 2).Genetic characterization
Whole viral genomes of these strains were further
sequenced to evaluate genetic mutations that might ex-
plain their biological behavior in cells and mice.
Sequences were deposited to Genbank [Genbank:
JF800142, JF800143, CY089607, CY089608, CY089609,
CY089610, CY089611, CY089612] for A/Nanchang/
8002/2009 (NC2), [Genbank: CY089613, CY089614,
CY089615, CY089616, CY089617, CY089618, CY089619,
CY089620] for A/Nanchang/8008/2009 (NC8) and [Gen-
bank: CY089621, CY089622, CY089623, CY089624,
CY089625, CY089626, CY089627, CY089628] for A/
Nanchang/8011/2009 (NC11) strain.
Several mutations were found in each gene segment with
respect to prototypic pdm H1N1 strains, A/California/
07/2009 and A/California/04/2009. Comparison be-
tween NC2, NC8 and NC11 genomes revealed that NC8
differed from NC2 and NC11 at three different positions
in polymerase subunits PB2-V227I, R299K and PA-
E243G. HA analysis also showed the substitution of ala-
nine at position 409 in NC2 and NC11 which was not
present in NC8 (Table 1). Experimental data have already
shown that NC2 and NC11 are more virulent than NC8
due to efficient viral replication; possibly these amino
acid residues in PB2, PA and HA gene have an important
role in host adaptation and the virulence of pdm H1N1
influenza virus. However, additional studies are required
to probe the biological relevance of these amino acid
changes.Genetic characterization of NA, PB1, NP, NS1 and M2
also showed various mutations in these segments;
however, none of them clearly defined the different
pathogeneses of these pdm H1N1 strains (additional file
3).
Discussion
Here we present the heterogeneous virulence of three
different strains of influenza H1N1 in human adenocar-
cinoma cells (A549) and mice that were isolated from
clinically similar human cases from South China in
December 2009. Two different patterns of biological
heterogeneity were observed: first, two strains (NC2 and
NC11) showed efficient viral replication and subsequent
effects on tissue histology, induction of proinflammatory
response and causing lethality in mice, although their
behavior was not totally identical and some minor differ-
ences in the kinetics of the disease in mice were
observed. Secondly, NC8 showed delayed replication that
eventually led to non-lethal infection and muted inflam-
matory response in mice. These results have a relevance
to the previously published epidemiological reports that
associate effective viral replication and delayed clearance
with disease severity in humans [9,15,16]. Most of the
previous studies agree that pdm H1N1 exert homoge-
neous and modest infection but with efficient pulmonary
viral replication in mice [17]; however, its pathogenesis is
more than that of seasonal strains [5,18] and subdued
compared with 1918 pandemic and other swine origin
influenza viruses [17,19]. Nonetheless, the virus has been
shown to increase virulence upon expression of truncated
viral proteins by reverse genetic tools and after mice
adaptation [20]. In addition to the heterogeneous nature
of these strains, we also demonstrate that C57/BL6 mice
are more susceptible for pdm H1N1 infection than
BALB/C strains; however, variation in disease kinetics
did not change the infectivity ratios as observed pre-
viously [14].
In this study, NC2 and NC11 viruses were able to in-
duce of proinflammatory cytokines effectively whereas
immune responses were mute in the case of NC8 infec-
tion. It is interesting to note that pdm H1N1 strains also
display a differential cytokine response which may or
may not be linked with viral growth. Previous studies
have shown a robust gene expression of innate immune
response genes with delayed switch to adaptive immun-
ity after pdm H1N1 infection; however, overall responses
are considered to be higher compared with those of
contemporary seasonal strains [7,17].
Clinically, 2009 influenza pandemic caused self
recovering mild disease in the vast majority of patients
while only a small group of patients developed serious
respiratory complications [21,22]. No explanation has yet
been offered for why the clinical profile varies from one
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host markers and viral pathogenesis in vitro and in vivo
are mostly limited to the characterization of a narrow
range of prototypic pdm H1N1 strains [5,17-19]. Conse-
quently, important aspects of the disease may remain
unexplored. Pandemics provide a greater chance for in-
fluenza viruses to mutate; however, unveiling their im-
pact on viral pathogenecity is an enduring goal that can
be achieved by continuous surveillance. Lab investigation
of newer strains might provide valuable information
about the pathogenesis that could be missing in initial
studies.
In the present study, although all these viral strains
were isolated from patients who finally recovered, the
viruses were able to produce biological heterogeneity in
mice that refute the common paradigm of the evaluation
of influenza pathogenesis which is at present based on
the clinical profile and disease outcome of patients. Such
attributes have previously been observed in clinically
relevant influenza H5N1 strains [23,24]. In humans, viral
heterogeneity may have specific effects on individuals
with different genetic background and demography;
therefore, infection with such viruses might result in a
variable clinical course of infection. However, it is also
important to remember that treatment strategies, immu-
nocompetance, and clinical management influence the
disease severity and outcome and consequently mask the
true picture of viral pathogenesis.
Virulence and interspecies transmission of influenza
virus is often considered a polygenic phenomena [25-
28]. The triple reassortant pandemic 2009 influenza
virus stands out from ancestral pandemic and reassorted
strains because it rapidly transmits to humans despite
the absence of any traditional virulence markers; for ex-
ample, the C-terminal PDZ ligand domain of NS1 [26],
functional PB1-F2 protein, and PB2- K627 [1]. Therefore,
efforts have been made to determine other possible viru-
lence determinant(s). Recent laboratory investigations
conducted with mouse adapted pdm H1N1 strains
speculate the role of HA (D131E and S186P) [29] and
PB2 genes, such as glutamate-to-glycine substitution at
158 [30], aspartate to asparagines at 701 [31], Threonine-
to-alanine at 271 [32] and second site suppressor muta-
tion [33] in viral replication and mouse adaptation, al-
though none of them was demonstrated in wild type
strains. In this study, the genetic characterization showed
that the non-lethal NC8 strain contained three mutations
(PB2-V227I, R299K and PA-E243G) in polymerase subu-
nits compared with virulent strains. Previous studies have
reported that both PB2 and PA genes are genetically
linked with each other [34]; furthermore, N-terminal
mutations in these genes might lead to intermediate or
complete loss of viral RNA transcription [35]. Therefore,
we might speculate that these mutations are interlinkedand collectively responsible for altered replication of the
NC8 strain. On the other hand, this virus (NC8) strik-
ingly replicated more than other viruses with> log10
ratio in embryonated chicken eggs, indicating the ease of
growth in an avian environment. Here it is important to
consider that the 2009 pandemic virus contains polymer-
ase subunits PB2 and PA of North American avian
lineage. We do not know whether these substitutions in
NC8 are the remains of ancestral avian strains or not,
but upon sequence analysis of global pdm H1N1 isolates,
we found that these amino acid residues (PB2-I227,
K299, PA-G243) are conserved in pdm H1N1 strains,
thus raising the possibility that collectively they have
some role in the adaptation to the mammalian host and
they might link to the heterogeneity of pdm H1N1.
However, in vivo studies with mutant strains are required
to prove the hypothesis. In the case of HA gene, NC2
and NC11 contained the A409V mutation compared to
NC8 and prototype California strains. It is worthwhile to
indicate that NC2 also exhibited HA-E391K, which has
recently been identified as a fast-growing mutation with
the ability to destabilize the HA oligomerization process,
thus modifying the membrane fusion properties of the
pandemic influenza virus [36,37]. However, no association
with virulence and progression of disease has been estab-
lished yet. Taken together, we hypothesize that these
mutations in PB2, PA and HA genes might have no rele-
vance with human disease but in the case of zoonotic
transmission of influenza viruses to human, it may yield
more pathogenic viruses.
Conclusions
In conclusion, the study provides evidence about the
heterogeneous replication and virulence of clinically
relevant pandemic influenza H1N1 viruses in mice and
human alveolar adenocarcinoma cells. Replication effi-
ciencies might link with the notable mutations in viral
polymerase complex genes PB2 and PA. Heterogeneous
virulence that the viruses displayed in cells and mice
may not be linked with the human disease; however, it
provides a background to understand the differences in
symptomatology, immune responses, and viral dynamics
of clinically relevant cases. The study mandates the more
comprehensive analysis of 2009 pandemic influenza
H1N1 strains and the factors which might be responsible
for a different phenotypic behavior in humans.
Methods
Viral strains
A total of three pandemic Influenza H1N1 strains,
namely A/Nanchang/8002/2009 (NC2), A/Nanchang/
8008/2009 (NC8), A/Nanchang/8011/2009 (NC11), were
used for in vitro and in vivo studies. All were isolated
from nasopharyngeal (NP) swabs of adult patients who
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province of China, in December 2009. Samples were
collected before initiation of virological treatment in
each case. These patients had similar courses of infec-
tion in terms of viral shedding and disease severity. They
had no underlying illnesses (Table 1). All patients even-
tually recovered. Viral isolation was attained in 9- to 11-
day-old embryonated eggs as described previously [38]
with the exception of incubation at 33 °C. Samples with
hemagglutination titer> 1:2 were considered positive
and further confirmed by real time RT-PCR for pdm
H1N1 virus using pandemic H1N1 influenza diagnostic
kit (Liferiver, Shanghai, China) based on World Health
Organization and US CDC protocol [39]. The viral
stocks were further titrated by egg infectious dose50
(EID50) and used for in vitro and in vivo assays without
further passage.Sequencing
Whole viral genome sequencing was performed for each
strain. RNA were extracted from NP swabs using Trizol
(invitrogen) followed by reverse transcription by high-
capacity cDNA RT kit (Applied Biosystems, Foster City,
USA) and PCR using primers specific for each viral gene
segment. Purified PCR preps (Promega, Madison, USA)
were sequenced from Invitrogen (Guangzhou, China).
Sequences were aligned and assessed by ClustalW mul-
tiple alignment tools. Comparisons were made with the
prototype strains A/California/04/2009 and A/California/
07/2009.Infection in human adenocarcinoma alveaolar epithelial
(A549) cells
An in vitro infection model was developed in adenocar-
cinoma human alveolar epithelial cells (A549) (ATCC,
USA). Briefly, A549 cells, freshly seeded in 24-well
plates, were infected with three different strains of pdm
H1N1 (NC2, NC8, NC11) at MOI 2 in vHAM’s F12
medium (M & C Gene Technology) containing 1 μg/ml
of TPCK trypsin. MOI was calculated by EID50 titers.
After 2 hrs of adsorption, cell supernatants were
replaced with fresh medium followed by incubation at
37 °C. Similar treatment with the exception of virus was
provided to uninfected cells (blank). Each point was per-
formed in six replicate wells and the experiment was
repeated thrice.
For kinetic studies, samples were collected at different
time points such as 8 h post infection, 1 day post infec-
tion (d.p.i.) and 2 d.p.i.. In the case of the viral loads,
supernatants were collected and titrated in MDCK cells
(ATCC). For the determination of immune mediators,
RNA was extracted using the SV total RNA isolation
system (Promega) and reverse transcribed with the high-capacity cDNA RT kit (Applied Biosystems, Foster City,
USA) followed by amplification using SYBR Green
master mix (Invitrogen). Relative gene expression was
calculated after normalization with human β-actin gene.Confocal laser fluorescent microscopy
A549 Cells seeded on 24-well plates containing cover
glass were infected with viral strains at MOI 2 for 1 h at
37 °C followed by washing with HEPES (sigma) thrice
and the addition of vHAMF12 medium (with no TPCK-
trypsin). Cells were incubated at 37 °C for different time
intervals, fixed with 2% paraformaldehyde and blocked
with 5% bovine serum albumin (BSA) (Sigma). Viral
staining was performed with influenza A nucleoprotein
antibody (southern biotech) for 16 h at 4 °C. Alexa fluor
555 goat anti mouse IgG (H+L) (Beyotime) diluted 1:
500 in PBS containing 0.05% Tween20 and 3% BSA was
used as a secondary antibody while cells were stained for
DNA using 4′,6, diamino-2-phenylindole (DAPI) (Sigma)
diluted 1:1000 in PBS. Slides were observed by confocal
laser fluorescence microscope (Olympus Fluoview
FV1000). Data is the representative of three independent
experiments.Animal experiments
Female C57/BL6 and BALB/C mice (8–10 weeks of age)
were obtained from Vital River Laboratory (Beijing,
China) and maintained on a standard animal diet in a
SPF facility with controlled temperature and humidity.
Initially, to compare the virulence and pathogenesis of
viral strains (NC2, NC8, NC11), C57/BL6 mice (n = 10)
were intranasally infected with 105 EID50 in a final vol-
ume of 50 μl. NC8 infection at a higher dose of 106
EID50 was further compared with NC2 and NC11 due to
non-lethal infection. To investigate the detailed virulence
profile of pdm H1N1 strains, MLD50 experiments were
set up in C57/BL6 and BALB/C mice. Animals were
grouped (n = 10) and infected with 10-fold diluted pdm
H1N1 influenza strains ranging from 106 to 103 per
mouse. Mock infection with HBSS was given to healthy
controls. Animals were observed daily for weight loss
and mortality up to 14 d.p.i.. A loss of more than 20% in
original body weight was considered the humane end
point for mortality.Viral loads
Three animals from each group were euthanized at days
0, 1 and 3 p.i. and their organs collected, i.e., lungs, liver
and brain. Organ homogenates were prepared in
vDMEM (10%w/v) and assayed for viral loads in MDCK
cells with the detection limit of 10 TCID50/ml as
described previously [14].
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On days 0, 1 and 3, p.i. animals were euthanized, and
lung tissues were removed and fixed in 10% buffered for-
malin. Fixed tissues were processed for paraffin wax-em-
bedded sectioning and 5 μm thin sections were stained
with hematoxylin and eosin (H & E) and observed;
pictures were taken using a Nikon Eclipse 80i micro-
scope (Nikon).
Measurement of cytokines by quantitative PCR (qPCR)
For the measurement of host immune response, lungs of
virus-infected animals (n = 5/group) were collected in an
RNAlater (Ambion Inc) at different time intervals.
Expression of immune response genes was studied by
real time qPCR performed with 0.5pmol/μl of forward
and reverse primers targeting the gene of interest. Reac-
tions were run in duplicate, and mean values were nor-
malized with β-actin gene expression. Primer pairs and
PCR conditions will be provided upon request.
Statistics
Statistical analyses were performed using PAWS Statis-
tics 18 (SPSS Inc., Chicago, IL, USA). Fisher’s exact and
Chi square tests were used for comparison of categorical
data, and the two-tailed t-test was applied in cases of
continuous variables. Survival analyses were performed
by the Kaplan-Meier method and significant differences
were measured by log-rank test. Contingency analysis
was applied to assess the number of survivors in each
group. Significant differences in viral loads, cytokine
measurement, and weight loss and hazard ratios were
analyzed by Student’s t-test.
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